Monitored COVID-19 mRNA vaccine second doses for people with adverse reactions after the first dose.
Allergy Asthma Proc
; 43(1): 37-39, 2022 Jan 01.
Article
in English
| MEDLINE | ID: covidwho-1604942
ABSTRACT
Background:
After Emergency Use Authorization of the coronavirus disease 2019 (COVID-19) vaccines, guidance was provided by the Centers for Disease Control and Prevention that persons with an immediate allergic reaction to a messenger RNA (mRNA) COVID-19 vaccine should be evaluated by an allergist/immunologist before receipt of the second dose.Methods:
In vaccinating health-care personnel, we referred those with significant reactions to allergy/immunology specialists so that they could safely receive the second dose.Results:
We found that many reactions after the first dose were nonallergic but could be debilitating and a barrier to the second dose. We created a protocol of premedications to allow health-care personnel to safely receive their second mRNA COVID-19 vaccine dose.Conclusion:
This protocol is adaptable and can be used in settings where allergy/immunology referral is not immediately available.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Vaccines, Synthetic
/
COVID-19 Vaccines
/
COVID-19
/
MRNA Vaccines
/
Anaphylaxis
Type of study:
Experimental Studies
Topics:
Vaccines
Limits:
Humans
Language:
English
Journal:
Allergy Asthma Proc
Journal subject:
Allergy and Immunology
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS